{"id":"W4385341021","doi":"10.1080/13696998.2023.2242197","title":"Cost-effectiveness analysis of cabozantinib compared with everolimus, axitinib, and nivolumab in subsequent line advanced renal cell carcinoma in Japan","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVRAZ (Canada)","funders":"Takeda Pharmaceutical Company","keywords":"Axitinib; Cabozantinib; Everolimus; Nivolumab; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Urology; Second line; Tyrosine-kinase inhibitor; Sunitinib; Immunotherapy; First line; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00599973,0.001347309,0.003063979,0.001683562,0.0003628719,0.001710715,0.001184971,0.0009894063,0.002531087],"category_scores_gemma":[0.01293829,0.0008473275,0.007616768,0.001487422,0.0005108796,0.00109112,0.00104791,0.00125292,0.00007720233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007498924,"about_ca_system_score_gemma":0.00443131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04496674,"about_ca_topic_score_gemma":0.0235059,"domain_scores_codex":[0.9968631,0.002124639,0.0002036605,0.0002941021,0.000199955,0.0003144144],"domain_scores_gemma":[0.9956765,0.002954536,0.0006434338,0.000127891,0.0002953247,0.0003023301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.03052132,0.001475721,0.08381037,0.005035537,0.02439895,0.001103829,0.0002069673,0.8166944,0.00124288,0.003284922,0.00219665,0.03002847],"study_design_scores_gemma":[0.01124302,0.007662012,0.1018381,0.001202633,0.05297399,0.0008737168,0.0008141396,0.8145525,0.001361386,0.00479017,0.002441521,0.000246698],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9744419,0.01534018,0.003687871,0.001206465,0.0001011944,0.0005924096,0.002337486,0.00003865817,0.002253774],"genre_scores_gemma":[0.9962294,0.001441132,0.001014441,0.0001335423,0.00001809633,0.0001841604,0.000751482,0.00000586321,0.0002219904],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04496674,"threshold_uncertainty_score":0.08941001,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04274972990295816,"score_gpt":0.3051754524786486,"score_spread":0.2624257225756904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}